November 2022 - Volume 80 - Issue 5 - Contributor Index

Alphabetical Search

Safety, Tolerability, and Effects of a Single Subcutaneous Administration of SP16 – a SERPIN-like, Small Peptide Agonist of the Low-Density Lipoprotein–like Receptor 1– on the Acute Inflammatory Response in Patients With ST-Segment Elevation Myocardial Infarction

Van Tassell, Benjamin W.; Wohlford, George F.; Del Buono, Marco Giuseppe; More

Journal of Cardiovascular Pharmacology. 80(5):672-678, November 2022.

Author:
Abe, Ko MD

Ethoxyquin is a Competent Radical-Trapping Antioxidant for Preventing Ferroptosis in Doxorubicin Cardiotoxicity

Tadokoro, Tomonori; Ikeda, Masataka; Abe, Ko; More

Journal of Cardiovascular Pharmacology. 80(5):690-699, November 2022.

Author:
Ai, Xun MD
Author:
Amin, Ghadir

Safety, Tolerability, and Effects of a Single Subcutaneous Administration of SP16 – a SERPIN-like, Small Peptide Agonist of the Low-Density Lipoprotein–like Receptor 1– on the Acute Inflammatory Response in Patients With ST-Segment Elevation Myocardial Infarction

Van Tassell, Benjamin W.; Wohlford, George F.; Del Buono, Marco Giuseppe; More

Journal of Cardiovascular Pharmacology. 80(5):672-678, November 2022.

Author:
Bai, Ting BS
Author:
Bao, Yu-Lin MD
Author:
Chen, Jing MD

Safety, Tolerability, and Effects of a Single Subcutaneous Administration of SP16 – a SERPIN-like, Small Peptide Agonist of the Low-Density Lipoprotein–like Receptor 1– on the Acute Inflammatory Response in Patients With ST-Segment Elevation Myocardial Infarction

Van Tassell, Benjamin W.; Wohlford, George F.; Del Buono, Marco Giuseppe; More

Journal of Cardiovascular Pharmacology. 80(5):672-678, November 2022.

Safety, Tolerability, and Effects of a Single Subcutaneous Administration of SP16 – a SERPIN-like, Small Peptide Agonist of the Low-Density Lipoprotein–like Receptor 1– on the Acute Inflammatory Response in Patients With ST-Segment Elevation Myocardial Infarction

Van Tassell, Benjamin W.; Wohlford, George F.; Del Buono, Marco Giuseppe; More

Journal of Cardiovascular Pharmacology. 80(5):672-678, November 2022.

Author:
Du, Chong MD

Ethoxyquin is a Competent Radical-Trapping Antioxidant for Preventing Ferroptosis in Doxorubicin Cardiotoxicity

Tadokoro, Tomonori; Ikeda, Masataka; Abe, Ko; More

Journal of Cardiovascular Pharmacology. 80(5):690-699, November 2022.

Author:
Gao, Ge MD

Safety, Tolerability, and Effects of a Single Subcutaneous Administration of SP16 – a SERPIN-like, Small Peptide Agonist of the Low-Density Lipoprotein–like Receptor 1– on the Acute Inflammatory Response in Patients With ST-Segment Elevation Myocardial Infarction

Van Tassell, Benjamin W.; Wohlford, George F.; Del Buono, Marco Giuseppe; More

Journal of Cardiovascular Pharmacology. 80(5):672-678, November 2022.

Contrast-induced Acute Kidney Injury in Diabetic Patients and SGLT-2 Inhibitors: A Preventive Opportunity or Promoting Element?

Nusca, Annunziata; Piccirillo, Francesco; Viscusi, Michele Mattia; More

Journal of Cardiovascular Pharmacology. 80(5):661-671, November 2022.

Safety, Tolerability, and Effects of a Single Subcutaneous Administration of SP16 – a SERPIN-like, Small Peptide Agonist of the Low-Density Lipoprotein–like Receptor 1– on the Acute Inflammatory Response in Patients With ST-Segment Elevation Myocardial Infarction

Van Tassell, Benjamin W.; Wohlford, George F.; Del Buono, Marco Giuseppe; More

Journal of Cardiovascular Pharmacology. 80(5):672-678, November 2022.

Contrast-induced Acute Kidney Injury in Diabetic Patients and SGLT-2 Inhibitors: A Preventive Opportunity or Promoting Element?

Nusca, Annunziata; Piccirillo, Francesco; Viscusi, Michele Mattia; More

Journal of Cardiovascular Pharmacology. 80(5):661-671, November 2022.

Author:
He, Qingqing BS
Author:
Ho, Jane PharmD

Safety, Tolerability, and Effects of a Single Subcutaneous Administration of SP16 – a SERPIN-like, Small Peptide Agonist of the Low-Density Lipoprotein–like Receptor 1– on the Acute Inflammatory Response in Patients With ST-Segment Elevation Myocardial Infarction

Van Tassell, Benjamin W.; Wohlford, George F.; Del Buono, Marco Giuseppe; More

Journal of Cardiovascular Pharmacology. 80(5):672-678, November 2022.

Author:
Huang, Nina MD
Author:
Huang, Yuan MD

Ethoxyquin is a Competent Radical-Trapping Antioxidant for Preventing Ferroptosis in Doxorubicin Cardiotoxicity

Tadokoro, Tomonori; Ikeda, Masataka; Abe, Ko; More

Journal of Cardiovascular Pharmacology. 80(5):690-699, November 2022.

Ethoxyquin is a Competent Radical-Trapping Antioxidant for Preventing Ferroptosis in Doxorubicin Cardiotoxicity

Tadokoro, Tomonori; Ikeda, Masataka; Abe, Ko; More

Journal of Cardiovascular Pharmacology. 80(5):690-699, November 2022.

Ethoxyquin is a Competent Radical-Trapping Antioxidant for Preventing Ferroptosis in Doxorubicin Cardiotoxicity

Tadokoro, Tomonori; Ikeda, Masataka; Abe, Ko; More

Journal of Cardiovascular Pharmacology. 80(5):690-699, November 2022.

Ethoxyquin is a Competent Radical-Trapping Antioxidant for Preventing Ferroptosis in Doxorubicin Cardiotoxicity

Tadokoro, Tomonori; Ikeda, Masataka; Abe, Ko; More

Journal of Cardiovascular Pharmacology. 80(5):690-699, November 2022.

Ethoxyquin is a Competent Radical-Trapping Antioxidant for Preventing Ferroptosis in Doxorubicin Cardiotoxicity

Tadokoro, Tomonori; Ikeda, Masataka; Abe, Ko; More

Journal of Cardiovascular Pharmacology. 80(5):690-699, November 2022.

Safety, Tolerability, and Effects of a Single Subcutaneous Administration of SP16 – a SERPIN-like, Small Peptide Agonist of the Low-Density Lipoprotein–like Receptor 1– on the Acute Inflammatory Response in Patients With ST-Segment Elevation Myocardial Infarction

Van Tassell, Benjamin W.; Wohlford, George F.; Del Buono, Marco Giuseppe; More

Journal of Cardiovascular Pharmacology. 80(5):672-678, November 2022.

Ethoxyquin is a Competent Radical-Trapping Antioxidant for Preventing Ferroptosis in Doxorubicin Cardiotoxicity

Tadokoro, Tomonori; Ikeda, Masataka; Abe, Ko; More

Journal of Cardiovascular Pharmacology. 80(5):690-699, November 2022.

Author:
Li, Jia MD
Author:
Li, Jian PhD
Author:
Li, Xiao MPharm
Author:
Li, Ying BS
Author:
Lin, Yaowang MD
Author:
Liu, Huadong MD
Author:
Liu, Yuanhui MD

Contrast-induced Acute Kidney Injury in Diabetic Patients and SGLT-2 Inhibitors: A Preventive Opportunity or Promoting Element?

Nusca, Annunziata; Piccirillo, Francesco; Viscusi, Michele Mattia; More

Journal of Cardiovascular Pharmacology. 80(5):661-671, November 2022.

Author:
Marawan, Amr MD

Safety, Tolerability, and Effects of a Single Subcutaneous Administration of SP16 – a SERPIN-like, Small Peptide Agonist of the Low-Density Lipoprotein–like Receptor 1– on the Acute Inflammatory Response in Patients With ST-Segment Elevation Myocardial Infarction

Van Tassell, Benjamin W.; Wohlford, George F.; Del Buono, Marco Giuseppe; More

Journal of Cardiovascular Pharmacology. 80(5):672-678, November 2022.

Safety, Tolerability, and Effects of a Single Subcutaneous Administration of SP16 – a SERPIN-like, Small Peptide Agonist of the Low-Density Lipoprotein–like Receptor 1– on the Acute Inflammatory Response in Patients With ST-Segment Elevation Myocardial Infarction

Van Tassell, Benjamin W.; Wohlford, George F.; Del Buono, Marco Giuseppe; More

Journal of Cardiovascular Pharmacology. 80(5):672-678, November 2022.

Ethoxyquin is a Competent Radical-Trapping Antioxidant for Preventing Ferroptosis in Doxorubicin Cardiotoxicity

Tadokoro, Tomonori; Ikeda, Masataka; Abe, Ko; More

Journal of Cardiovascular Pharmacology. 80(5):690-699, November 2022.

Contrast-induced Acute Kidney Injury in Diabetic Patients and SGLT-2 Inhibitors: A Preventive Opportunity or Promoting Element?

Nusca, Annunziata; Piccirillo, Francesco; Viscusi, Michele Mattia; More

Journal of Cardiovascular Pharmacology. 80(5):661-671, November 2022.

Ethoxyquin is a Competent Radical-Trapping Antioxidant for Preventing Ferroptosis in Doxorubicin Cardiotoxicity

Tadokoro, Tomonori; Ikeda, Masataka; Abe, Ko; More

Journal of Cardiovascular Pharmacology. 80(5):690-699, November 2022.

Contrast-induced Acute Kidney Injury in Diabetic Patients and SGLT-2 Inhibitors: A Preventive Opportunity or Promoting Element?

Nusca, Annunziata; Piccirillo, Francesco; Viscusi, Michele Mattia; More

Journal of Cardiovascular Pharmacology. 80(5):661-671, November 2022.

Author:
Ozbey, Gul MD

Contrast-induced Acute Kidney Injury in Diabetic Patients and SGLT-2 Inhibitors: A Preventive Opportunity or Promoting Element?

Nusca, Annunziata; Piccirillo, Francesco; Viscusi, Michele Mattia; More

Journal of Cardiovascular Pharmacology. 80(5):661-671, November 2022.

Contrast-induced Acute Kidney Injury in Diabetic Patients and SGLT-2 Inhibitors: A Preventive Opportunity or Promoting Element?

Nusca, Annunziata; Piccirillo, Francesco; Viscusi, Michele Mattia; More

Journal of Cardiovascular Pharmacology. 80(5):661-671, November 2022.

Author:
Sun, Xiaohua MD
Author:
Sun, Xin MD

Ethoxyquin is a Competent Radical-Trapping Antioxidant for Preventing Ferroptosis in Doxorubicin Cardiotoxicity

Tadokoro, Tomonori; Ikeda, Masataka; Abe, Ko; More

Journal of Cardiovascular Pharmacology. 80(5):690-699, November 2022.

Safety, Tolerability, and Effects of a Single Subcutaneous Administration of SP16 – a SERPIN-like, Small Peptide Agonist of the Low-Density Lipoprotein–like Receptor 1– on the Acute Inflammatory Response in Patients With ST-Segment Elevation Myocardial Infarction

Van Tassell, Benjamin W.; Wohlford, George F.; Del Buono, Marco Giuseppe; More

Journal of Cardiovascular Pharmacology. 80(5):672-678, November 2022.

Author:
Tao, Linqing BS

Safety, Tolerability, and Effects of a Single Subcutaneous Administration of SP16 – a SERPIN-like, Small Peptide Agonist of the Low-Density Lipoprotein–like Receptor 1– on the Acute Inflammatory Response in Patients With ST-Segment Elevation Myocardial Infarction

Van Tassell, Benjamin W.; Wohlford, George F.; Del Buono, Marco Giuseppe; More

Journal of Cardiovascular Pharmacology. 80(5):672-678, November 2022.

Author:
Tian, Nani BS

Ethoxyquin is a Competent Radical-Trapping Antioxidant for Preventing Ferroptosis in Doxorubicin Cardiotoxicity

Tadokoro, Tomonori; Ikeda, Masataka; Abe, Ko; More

Journal of Cardiovascular Pharmacology. 80(5):690-699, November 2022.

Safety, Tolerability, and Effects of a Single Subcutaneous Administration of SP16 – a SERPIN-like, Small Peptide Agonist of the Low-Density Lipoprotein–like Receptor 1– on the Acute Inflammatory Response in Patients With ST-Segment Elevation Myocardial Infarction

Van Tassell, Benjamin W.; Wohlford, George F.; Del Buono, Marco Giuseppe; More

Journal of Cardiovascular Pharmacology. 80(5):672-678, November 2022.

Contrast-induced Acute Kidney Injury in Diabetic Patients and SGLT-2 Inhibitors: A Preventive Opportunity or Promoting Element?

Nusca, Annunziata; Piccirillo, Francesco; Viscusi, Michele Mattia; More

Journal of Cardiovascular Pharmacology. 80(5):661-671, November 2022.

Safety, Tolerability, and Effects of a Single Subcutaneous Administration of SP16 – a SERPIN-like, Small Peptide Agonist of the Low-Density Lipoprotein–like Receptor 1– on the Acute Inflammatory Response in Patients With ST-Segment Elevation Myocardial Infarction

Van Tassell, Benjamin W.; Wohlford, George F.; Del Buono, Marco Giuseppe; More

Journal of Cardiovascular Pharmacology. 80(5):672-678, November 2022.